(Q46936282)

26 December 2017

title

Genes associated with intestinal permeability in ulcerative colitis: changes in expression following infliximab therapy (English)

1 reference

26 December 2017

13

Paul Rutgeerts

1 reference

26 December 2017

11

James D Lewis

1 reference

26 December 2017

author name string

Gary Toedter

1

1 reference

26 December 2017

Katherine Li

2

1 reference

26 December 2017

Sarah Sague

3

1 reference

26 December 2017

Keying Ma

4

1 reference

26 December 2017

Colleen Marano

5

1 reference

26 December 2017

Michael Macoritto

6

1 reference

26 December 2017

Jennifer Park

7

1 reference

26 December 2017

Renée Deehan

8

1 reference

26 December 2017

Andrea Matthews

9

1 reference

26 December 2017

Gary D Wu

10

1 reference

26 December 2017

Ingrid Arijs

12

1 reference

26 December 2017

Frédéric Baribaud

14

1 reference

26 December 2017

language of work or name

1 reference

4 January 2012

1 reference

26 December 2017

Inflammatory Bowel Diseases

published in

1 reference

26 December 2017

volume

18

1 reference

26 December 2017

issue

8

1 reference

26 December 2017

page(s)

1399-1410

1 reference

26 December 2017

Inflammatory bowel disease: cause and immunobiology

cites work

1 reference

Inflammatory bowel disease: Established and evolving considerations on its etiopathogenesis and therapy

21 January 2018

1 reference

Altered permeability in inflammatory bowel disease: pathophysiology and clinical implications

21 January 2018

1 reference

Altered tight junction structure contributes to the impaired epithelial barrier function in ulcerative colitis

21 January 2018

1 reference

Intestinal fibrosis in inflammatory bowel disease: progress in basic and clinical science

21 January 2018

1 reference

Infliximab for induction and maintenance therapy for ulcerative colitis

21 January 2018

1 reference

Binding and Functional Comparisons of Two Types of Tumor Necrosis Factor Antagonists

21 January 2018

1 reference

Infliximab treatment induces apoptosis of lamina propria T lymphocytes in Crohn's disease.

21 January 2018

1 reference

Review article: targeting TNF alpha as a key cytokine in the inflammatory processes of Crohn's disease--the mechanisms of action of infliximab

21 January 2018

1 reference

Gene expression profiling and response signatures associated with differential responses to infliximab treatment in ulcerative colitis

21 January 2018

1 reference

Anti-tumor necrosis factor treatment restores the gut barrier in Crohn's disease

21 January 2018

1 reference

Small molecule activators of SIRT1 replicate signaling pathways triggered by calorie restriction in vivo

21 January 2018

1 reference

Causal reasoning identifies mechanisms of sensitivity for a novel AKT kinase inhibitor, GSK690693.

21 January 2018

1 reference

Epithelial tight junctions in intestinal inflammation

21 January 2018

1 reference

Role of the intestinal barrier in inflammatory bowel disease

21 January 2018

1 reference

A porous defense: the leaky epithelial barrier in intestinal disease.

21 January 2018

1 reference

Claudin-2 expression induces cation-selective channels in tight junctions of epithelial cells

21 January 2018

1 reference

Claudin-1 and claudin-2 expression is elevated in inflammatory bowel disease and may contribute to early neoplastic transformation

21 January 2018

1 reference

Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease

21 January 2018

1 reference

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

21 January 2018

1 reference

Correlation of plasma MMP-1 and TIMP-1 levels and the colonic mucosa expressions in patients with ulcerative colitis

21 January 2018

1 reference

Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease

21 January 2018

1 reference

Matrilysin (MMP-7) promotes invasion of ovarian cancer cells by activation of progelatinase

21 January 2018

1 reference

Collagenase-1 (MMP-1), matrilysin-1 (MMP-7), and stromelysin-2 (MMP-10) are expressed by migrating enterocytes during intestinal wound healing

21 January 2018

1 reference

Epilysin, a novel human matrix metalloproteinase (MMP-28) expressed in testis and keratinocytes and in response to injury

21 January 2018

1 reference

Epilysin (MMP-28) expression is associated with cell proliferation during epithelial repair

21 January 2018

1 reference

Epilysin (MMP-28)--structure, expression and potential functions

21 January 2018

1 reference

Autoregulation of Th1-mediated inflammation by twist1.

21 January 2018

1 reference

Molecular mechanism of tumor necrosis factor-alpha modulation of intestinal epithelial tight junction barrier

21 January 2018

1 reference

Interferon-gamma directly affects barrier function of cultured intestinal epithelial monolayers

21 January 2018

1 reference

Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

21 January 2018

1 reference

A randomized trial of Ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with moderate-to-severe Crohn's disease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IBD.22853

1 reference

26 December 2017

PubMed ID

22223479

1 reference

26 December 2017